[1] Ning T T, Liu S, Xu J X, et al. Potential intestinal infection and faecal-oral transmission of human coronaviruses[J]. Rev Med Virol, 2022, 32(6): e2363.
[2] Xiao F, Tang M W, Zheng X B, et al. Evidence for gastrointestinal infection of SARS-CoV-2[J]. Gastroenterology, 2020, 158(6): 1831-1833.e3.
[3] Harmer D, Gilbert M, Borman R, et al. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme[J]. FEBS Lett, 2002, 532(1/2): 107-110.
[4] Dekker E, Tanis P J, Vleugels J L A, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480.
[5] Liu C, Wang K, Zhang M, et al. High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients[J]. NPJ Precis Oncol, 2021, 5(1): 1.
[6] Nie J H, Li Q Q, Wu J J, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2[J]. Emerg Microbes Infect, 2020, 9(1): 680-686.
[7] Chen Z N, Mi L, Xu J Y, et al. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus[J]. J Infect Dis, 2005, 191(5): 755-760.
[8] Glowacka I, Bertram S, Müller M A, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response[J]. J Virol, 2011, 85(9): 4122-4134.
[9] Huang I C, Bosch B J, Li F, et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells[J]. J Biol Chem, 2006, 281(6): 3198-3203.
[10] Yang Z Y, Huang Y, Ganesh L, et al. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN[J]. J Virol, 2004, 78(11): 5642-5650.
[11] Matsuyama S, Nagata N, Shirato K, et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2[J]. J Virol, 2010, 84(24): 12658-12664.
[12] Jeffers S A, Tusell S M, Gillim-Ross L, et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus[J]. Proc Natl Acad Sci U S A, 2004, 101(44): 15748-15753.
[13] Winstone H, Lista M J, Reid A C, et al. The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type Ⅰ interferon and IFITM2[J]. J Virol, 2021, 95(9): e02422-20.
[14] Shi G L, Kenney A D, Kudryashova E, et al. Opposing activities of IFITM proteins in SARS-CoV-2 infection[J]. EMBO J, 2021, 40(3): e106501.
[15] Shulla A, Heald-Sargent T, Subramanya G, et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry[J]. J Virol, 2011, 85(2): 873-882.
[16] Huang I C, Bailey C C, Weyer J L, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus[J]. PLoS Pathog, 2011, 7(1): e1001258.
|